How PFE and XOM Became Turmoil Insurance in a Rotating Market episode artwork

EPISODE · Jun 11, 2026 · 9 MIN

How PFE and XOM Became Turmoil Insurance in a Rotating Market

from The Quarterly Review with Fexingo: Earnings, Reporting, and Performance Analysis for Businesses · host Fexingo

Episode 44 of The Quarterly Review examines the growing appeal of defensive dividend stocks as the S&P 500 sits at 7,267 and the Nasdaq lingers around 25,170 after a sharp rotation out of tech. Lucas and Luna break down why Pfizer (PFE) and ExxonMobil (XOM) are being called 'turmoil insurance' this June 2026 — Pfizer yielding over 4.5 percent with a drug pipeline that includes a blockbuster RSV vaccine, and Exxon riding steady cash flows from Permian production even as oil prices hover near $70. They discuss how the Russell 2000 dropped 2.3 percent in five days while value ETFs like IWD held flat, hinting that investors are hiding in large-cap value rather than chasing small-cap risk. The episode also covers how nominal GDP hit $31.8 trillion, reinforcing that corporate earnings can grow even as the economy decelerates. No ads — just a focused 10-minute conversation on one specific strategy reshaping portfolios right now. #Pfizer #ExxonMobil #DividendStocks #DefensiveRotation #MarketVolatility #S&P500 #NASDAQ #Russell2000 #ValueInvesting #TurmoilInsurance #June2026 #FedPolicy #GDP #PharmaStocks #EnergyStocks #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

Episode 44 of The Quarterly Review examines the growing appeal of defensive dividend stocks as the S&P 500 sits at 7,267 and the Nasdaq lingers around 25,170 after a sharp rotation out of tech. Lucas and Luna break down why Pfizer (PFE) and ExxonMobil (XOM) are being called 'turmoil insurance' this June 2026 — Pfizer yielding over 4.5 percent with a drug pipeline that includes a blockbuster RSV vaccine, and Exxon riding steady cash flows from Permian production even as oil prices hover near $70. They discuss how the Russell 2000 dropped 2.3 percent in five days while value ETFs like IWD held flat, hinting that investors are hiding in large-cap value rather than chasing small-cap risk. The episode also covers how nominal GDP hit $31.8 trillion, reinforcing that corporate earnings can grow even as the economy decelerates. No ads — just a focused 10-minute conversation on one specific strategy reshaping portfolios right now. #Pfizer #ExxonMobil #DividendStocks #DefensiveRotation #MarketVolatility #S&P500 #NASDAQ #Russell2000 #ValueInvesting #TurmoilInsurance #June2026 #FedPolicy #GDP #PharmaStocks #EnergyStocks #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo

NOW PLAYING

How PFE and XOM Became Turmoil Insurance in a Rotating Market

0:00 9:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Quarterly Review with Fexingo: Earnings, Reporting, and Performance Analysis for Businesses?

This episode is 9 minutes long.

When was this The Quarterly Review with Fexingo: Earnings, Reporting, and Performance Analysis for Businesses episode published?

This episode was published on June 11, 2026.

What is this episode about?

Episode 44 of The Quarterly Review examines the growing appeal of defensive dividend stocks as the S&P 500 sits at 7,267 and the Nasdaq lingers around 25,170 after a sharp rotation out of tech. Lucas and Luna break down why Pfizer (PFE) and...

Can I download this The Quarterly Review with Fexingo: Earnings, Reporting, and Performance Analysis for Businesses episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!